Join Now

Author Archives: Press Release

Recursion is Granted Orphan Drug Designation for REC-4881 for the Potential Treatment of Familial Adenomatous Polyposis

Recursion announced that the U.S. Food and Drug Administration (FDA) has granted the company orphan drug designation for REC-4881 for the potential treatment of familial adenomatous polyposis (FAP).

Posted in BioUtah News | Tagged | Leave a comment

NIH AWARDS SINTX TECHNOLOGIES PHASE 1 GRANT FOR SN-PEEK 3D PRINTED SPINAL IMPLANTS

SINTX Technologies, Inc., an original equipment manufacturer of advanced ceramics, announced today a Phase 1 grant of $308,301 awarded by the National Institute of Health (NIH) to develop a 3-D printed, composite silicon nitride – polyetheretherketone (SN-PEEK) spinal implant.

Posted in BioUtah News | Tagged | Leave a comment

SINTX ARMOR SHIPS FIRST ORDER AND PREPARES FOR MOVE TO UTAH

SINTX Technologies, Inc., an original equipment manufacturer of advanced ceramics, announced today that its newly created and wholly-owned subsidiary, SINTX Armor, will be located in Salt Lake City, Utah and that it has signed a 10-year lease on a facility to house development and manufacturing activities for SINTX Armor.

Posted in BioUtah News | Tagged | Leave a comment

Co-Diagnostics, Inc. to Introduce At Home/Point of Care Device at AACC on Sept 28

In addition to hosting a booth to promote its existing diagnostics products at the conference, the Company will also hold a press conference to introduce its upcoming at-home and point-of-care PCR device.

Posted in BioUtah News | Tagged , | Leave a comment

Owlet is changing the future of wearable devices

Recently, Owlet’s smart sock was used in a study of infant tachyarrhythmia, a condition where the heart beats much more rapidly than it should be for the level of exertion, reports Utah Business Magazine.

Posted in BioUtah News | Tagged | Leave a comment

Groundbreaking Children’s Genomics Study at Intermountain Primary Children’s Hospital Provides New Options for Children to Participate

The groundbreaking HerediGene: Children’s Study – the world’s largest DNA mapping effort ever to be undertaken in kids – is now offering additional collection methods for children to participate at Intermountain Primary Children’s Hospital, including a new simple cheek swab.

Posted in BioUtah News | Tagged | Leave a comment

Epitel Publication accepted for Special Edition of Frontiers Neurology

Epitel’s second publication has been accepted for publication in a special edition of Frontiers Neurology.

Posted in BioUtah News | Tagged | Leave a comment

Intermountain Healthcare Launches New Outpatient Imaging Services Company

Intermountain Healthcare is launching Tellica Imaging, a subsidiary company which will open and operate stand-alone outpatient imaging centers at easy-to-access locations.

Posted in BioUtah News | Tagged , | Leave a comment

Foldax Completes Enrollment in Early Feasibility Study for TRIA Biopolymer Surgical Aortic Heart Valve

Foldax®, Inc. announced completion of enrollment in the U.S. early feasibility study of the TRIA™ surgical aortic heart valve.

Posted in BioUtah News | Tagged | Leave a comment

IONIQ Sciences Announces Dr. Benjamin Haibe-Kains has joined its Scientific Advisory Committee

On September 27, 2021, IONIQ Sciences announced that Dr. Benjamin Haibe-Kains has joined its Scientific Advisory Committee.

Posted in BioUtah News | Tagged | Leave a comment

Co-Diagnostics, Inc. Announces Corporate Rebranding Following Period of Transformative Growth and Expansion

Co-Diagnostics, Inc. announced that following its recent transformative growth, the Company is rebranding its image to better reflect its expanded scope, mission, and upcoming expansion into new diagnostics verticals.

Posted in BioUtah News | Tagged | Leave a comment

AdvaMed Statement on Administration’s Opposition to Expanding Medicare Patient Access to Breakthrough Medicare Technologies

AdvaMed, the leading global trade association for medical technology manufacturers, released the following statement from President and CEO Scott Whitaker on the Administration’s proposal to fully repeal the Medicare Coverage of Innovative Technologies (MCIT) rule.

Posted in BioUtah News | Tagged | Leave a comment